Form 4: David E. Lazar Increases Stake in OpGen Inc. with Series E Convertible Preferred Stock Acquisition

David E. Lazar, a director, 10% owner, and CEO of OpGen Inc., acquired an additional 200,000 shares of Series E Convertible Preferred Stock on April 5, 2024, further increasing his stake in the company.

Summary

• David E. Lazar, who is a director, 10% owner, and the CEO of OpGen Inc., filed a Form 4 detailing changes in his beneficial ownership of the company's securities.
• On March 25, 2024, Lazar entered into a securities purchase agreement with OpGen to acquire 3,000,000 shares of Series E Convertible Preferred Stock at $1.00 per share.
• The initial closing occurred on March 25, 2024, with Lazar acquiring 200,000 shares for $200,000.
• An additional closing took place on April 5, 2024, where Lazar acquired another 200,000 shares for $200,000.
• Each share of Series E Preferred Stock is convertible into 24 shares of OpGen's Common Stock, subject to certain ownership limitations.
• Lazar will acquire additional shares of Series E Preferred Stock at subsequent closings, contingent upon certain conditions being met.
• As of April 5, 2024, following the reported transaction, Lazar beneficially owns 9,600,000 shares of Common Stock and 400,000 shares of Series E Convertible Preferred Stock, which can be converted into 9,600,000 shares of common stock.

Sentiment

Score: 7

Explanation: The sentiment is moderately positive as the CEO is increasing his investment in the company, which can be seen as a sign of confidence. However, the potential dilution from the conversion of preferred stock needs to be considered.

Positives

• The CEO's increased investment in the company could be seen as a positive signal to the market.

Risks

• The conversion of preferred stock into common stock could potentially dilute existing shareholders' equity.

Future Outlook

Lazar will acquire additional shares of Series E Preferred Stock at subsequent closings, subject to certain conditions being satisfied.

Industry Context

This filing reflects insider activity, which is closely monitored by investors for signals about a company's prospects. Significant insider purchases can be interpreted as a sign of confidence in the company's future performance.

Related Party Transactions

• The securities purchase agreement between David E. Lazar (CEO, Director, and 10% owner) and OpGen, Inc. is a related party transaction.

Stakeholder Impact

• Shareholders may experience dilution if the Series E Preferred Stock is converted into Common Stock.
• The company benefits from the capital injection from the sale of Series E Preferred Stock.

Next Steps

• Lazar will continue to acquire additional shares of Series E Preferred Stock at subsequent closings, subject to certain conditions.

Key Dates